Inventor · disambiguated record
Ronald Herbst
Also filed as: HERBST RONALD · HERBST RONALD S
19 granted patents·16 pending applications·115 citations·filing 1994–2025
94Inventor score
Files withMEDIMMUNE LLC15VIELA BIO INC7BOSTON PHARMACEUTICALS INC4BATTELLE ENERGY ALLIANCE LLC2ALITALO KARI1
Top patents by PatentIndex Score
35 records- 0193US10457732B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Oct 29, 2019·10 cites·12 claims
- 0293US8323653B2Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseDAMSCHRODER MELISSA·Filed 2007·Granted Dec 4, 2012·32 cites·9 claims
- 0392US8883992B2Humanized anti-CD19 antibodiesMEDIMMUNE LLC·Filed 2012·Granted Nov 11, 2014·11 cites·9 claims
- 0489USRE49908EBispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Apr 9, 2024·1 cites·43 claims
- 0589US11279759B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Mar 22, 2022·4 cites·19 claims
- 0687US2024417460A1Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseVIELA BIO INC·Filed 2024·Application pending·0 cites
- 0787US2025074986A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0886US9896505B2Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2014·Granted Feb 20, 2018·5 cites·8 claims
- 0985US7807606B2High capacity adsorption media and method of producingBATTELLE ENERGY ALLIANCE LLC·Filed 2005·Granted Oct 5, 2010·7 cites·21 claims
- 1083US10000553B2CD40L-specific TN3-derived scaffolds and methods of use thereofMEDIMMUNE LLC·Filed 2012·Granted Jun 19, 2018·6 cites·19 claims
- 1183US6270737B1Extraction processes and solvents for recovery of cesium, strontium, rare earth elements, technetium and actinides from liquid radioactive wasteUS ENERGY·Filed 2000·Granted Aug 7, 2001·23 cites·26 claims
- 1278US2023242619A1Compositions comprising a tn3 scaffold and methods of using the sameVIELA BIO INC·Filed 2022·Application pending·0 cites
- 1377US11104720B2Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunitVIELA BIO INC·Filed 2018·Granted Aug 31, 2021·1 cites·22 claims
- 1475US2023201346A1Binding molecules specific for il-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1575US2022251204A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 1674US11555062B2Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomerVIELA BIO INC·Filed 2021·Granted Jan 17, 2023·0 cites·39 claims
- 1773US10022443B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2015·Granted Jul 17, 2018·1 cites·17 claims
- 1873US2021061906A1Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseVIELA BIO INC·Filed 2020·Application pending·0 cites
- 1972US2025257120A1Compositions comprising a tn3 scaffold and methods of using the sameVIELA BIO INC·Filed 2025·Application pending·0 cites
- 2067US11529415B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·0 cites·14 claims
- 2167US10588969B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·0 cites·14 claims
- 2263US2018273621A1Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseVIELA BIO INC·Filed 2018·Application pending·0 cites
- 2361US10400035B2Methods of protecting a solid organ transplant tissue with angiopoietin-2 antibodiesMEDIMMUNE LLC·Filed 2017·Granted Sep 3, 2019·0 cites·4 claims
- 2457US7608643B2Compounds for inhibiting KSP kinesin activitySCHERING CORP·Filed 2006·Granted Oct 27, 2009·0 cites·7 claims
- 2557US2015044227A1Methods of treatment with angiopoietin-2 antibodiesALITALO KARI·Filed 2013·Application pending·0 cites
- 2654US7947861B2Methods of removing a constituent from a feed stream using adsorption mediaBATTELLE ENERGY ALLIANCE LLC·Filed 2010·Granted May 24, 2011·0 cites·18 claims
- 2754US2021260159A1CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOFMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 2852US10975155B2CD40L-Fc fusion polypeptides and methods of use thereofMEDIMMUNE LLC·Filed 2017·Granted Apr 13, 2021·0 cites·2 claims
- 2949US2020199567A1Methods for selection and expansion of t cells expressing pd-1MEDIMMUNE LLC·Filed 2019·Application pending·0 cites
- 3046US5419887ASeparation of the isotopes of boron by chemical exchange reactionsRES & DEV I INC·Filed 1994·Granted May 30, 1995·14 cites·3 claims
- 3144US2016222099A1Methods Of Treatment With Angiopoietin-2 AntibodiesMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 3244US2019241659A1Bispecific fusion polypeptides and methods of use thereofMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 3342US2019292259A1Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)INST NAT SANTE RECH MED·Filed 2017·Application pending·0 cites
- 3442US2015044168A1Treatment of Multiple Sclerosis With Anti-CD19 AntibodyMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 3534US2013330328A1Combination Therapy For B Cell LymphomasHERBST RONALD·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ronald Herbst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →